Carregant...
Comparison of classification methods that combine clinical data and high-dimensional mass spectrometry data
BACKGROUND: The identification of new diagnostic or prognostic biomarkers is one of the main aims of clinical cancer research. Technologies like mass spectrometry are commonly being used in proteomic research. Mass spectrometry signals show the proteomic profiles of the individuals under study at a...
Guardat en:
| Publicat a: | BMC Bioinformatics |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261611/ https://ncbi.nlm.nih.gov/pubmed/25432156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-014-0385-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|